Aradhana Kaushal, MD

Articles by Aradhana Kaushal, MD

Primary Radiation Therapy for Myeloid Sarcoma of the Porta Hepatis

ByCharlton A. Smith, MD,MiloÅ¡ MiljkoviÄ‡, MD,Ashkan Malayeri, MD,Jason Y. Cheng, PhD,Kevin A. Camphausen, MD,Dennis D. Hickstein, MD,Aradhana Kaushal, MD

April 9th 2016

Treating myeloid sarcoma at the porta hepatis with 24 Gy over 12 fractions is a well-tolerated treatment that achieved a complete, durable response with minimal toxicity.

Latest Updated Articles

Primary Radiation Therapy for Myeloid Sarcoma of the Porta Hepatis
April 9th 2016

Aradhana Kaushal, MD

Articles by Aradhana Kaushal, MD

Primary Radiation Therapy for Myeloid Sarcoma of the Porta Hepatis

Latest Updated Articles

Trending on OncLive

FDA Grants Fast Track Designation to Sapanisertib and Serabelisib Plus Paclitaxel in Advanced Endometrial Cancer

T-DXd Improves PFS in First-Line HER2-Mutant NSCLC

Dr Leary on a Neo-Epitope-Based Vaccine With or Without Pembrolizumab in Platinum-Sensitive Recurrent Ovarian Cancer

FDA Grants Fast Track Designation to BH-30643 in EGFR C797S+ NSCLC

Dr Viansone on ADC Sequencing in Metastatic HER2+ Breast Cancer